https://www.selleckchem.com/pr....oducts/pf-06424439.h
Visits declined to prepandemic levels between October 4, 2020 and March 13, 2021, after which visits began to rise. Naloxone and buprenorphine were prescribed within 30 days at 7.4% and 8.5% of the 148,966 visits, respectively. The naloxone prescribing rate (7.4%) was substantially lower than the epinephrine prescribing rate (48.9%) after ED visits for anaphylaxis. Between August 4, 2019, and April 3, 2021, naloxone and buprenorphine were only prescribed after 1 in 12 and 1 in 13 ED visits for opioid overdose, respectively. Findings
Like
Comment
Share
